Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bressolle

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics|March 31, 1999
Predictive performance of a semiparametric method to estimate population pharmacokinetic parameters using NONMEMF Bressolle, R Gomeni
Therapie|November 1, 1985
[Plasma, erythrocyte and urinary pharmacokinetics of sultopride in man]J Bres, F Bressolle
Journal of Pharmaceutical Sciences|December 1, 1991
Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrationsJ Brès, F Bressolle
Journal - Association of Official Analytical Chemists|May 1, 1980
Thin layer chromatography reflectometric determination of benzoic and sorbic acids in fruit beveragesB Mandrou, F Bressolle
Il Farmaco; Edizione Pratica|June 1, 1985
[Pharmacokinetics of naftazone in the dog]F Bressolle, J Bres
Fundamental & Clinical Pharmacology|August 26, 1998
Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotenceC Marquer, F Bressolle
Clinical Pharmacokinetics|September 18, 1998
Pharmacodynamics and pharmacokinetics of thiopentalH Russo, F Bressolle
Journal of Chromatography|June 14, 1985
[Determination of sulpiride and sultopride by high-performance liquid chromatography for pharmacokinetic studies]F Bressolle, J Bres
Journal of Chromatography. B, Biomedical Sciences and Applications|April 11, 1997
High-performance liquid chromatographic determination of the conjugate metabolites of moxisylyte in human plasma and urineC Marquer, F Bressolle
Journal of Pharmacokinetics and Pharmacodynamics|December 10, 2024
Model-informed approach to estimate treatment effect in placebo-controlled clinical trials using an artificial intelligence-based propensity weighting methodology to account for non-specific responses to treatmentRoberto Gomeni, F Bressolle-Gomeni
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Journal of Pharmacokinetics and Biopharmaceutics|March 31, 1999
Predictive performance of a semiparametric method to estimate population pharmacokinetic parameters using NONMEMF Bressolle, R Gomeni
Therapie|November 1, 1985
[Plasma, erythrocyte and urinary pharmacokinetics of sultopride in man]J Bres, F Bressolle
Journal of Pharmaceutical Sciences|December 1, 1991
Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrationsJ Brès, F Bressolle
Journal - Association of Official Analytical Chemists|May 1, 1980
Thin layer chromatography reflectometric determination of benzoic and sorbic acids in fruit beveragesB Mandrou, F Bressolle
Il Farmaco; Edizione Pratica|June 1, 1985
[Pharmacokinetics of naftazone in the dog]F Bressolle, J Bres
Fundamental & Clinical Pharmacology|August 26, 1998
Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotenceC Marquer, F Bressolle
Clinical Pharmacokinetics|September 18, 1998
Pharmacodynamics and pharmacokinetics of thiopentalH Russo, F Bressolle
Journal of Chromatography|June 14, 1985
[Determination of sulpiride and sultopride by high-performance liquid chromatography for pharmacokinetic studies]F Bressolle, J Bres
Journal of Chromatography. B, Biomedical Sciences and Applications|April 11, 1997
High-performance liquid chromatographic determination of the conjugate metabolites of moxisylyte in human plasma and urineC Marquer, F Bressolle
Journal of Pharmacokinetics and Pharmacodynamics|December 10, 2024
Model-informed approach to estimate treatment effect in placebo-controlled clinical trials using an artificial intelligence-based propensity weighting methodology to account for non-specific responses to treatmentRoberto Gomeni, F Bressolle-Gomeni
Pageof 16